Cohen Guy, Jakus Jeannette, Portillo Mauricio, Gvirtz Raanan, Ogen-Shtern Navit, Silberstein Eldad, Ayzenberg Tomer, Rozenblat Sharon
The Skin Research Institute, The Dead Sea and Arava Science Center, Masada, Israel.
Ben Gurion University of the Negev, Eilat, Israel.
J Cosmet Dermatol. 2023 Nov;22(11):3047-3057. doi: 10.1111/jocd.15815. Epub 2023 Jun 1.
Skin aging manifestation, such as coarse wrinkles, loss of elasticity, pigmentation, and rough-textured appearance, is a multifactorial process that can be exacerbated by air pollution, smoking, poor nutrition, and sun exposure. Exposure to UV radiation is considered the primary cause of extrinsic skin aging and accounts for about 80% of facial aging. Extrinsic skin aging signs can be reduced with demo-cosmetic formulations. Both cannabidiol (CBD) and eicosapentaenoic acid (EPA) have been previously suggested as potent active dermatological ingredients.
The objective of the current research was to evaluate the compatibility of both agents in the prevention and treatment of skin aging. First, the impact of both agents was assessed using standard photoaging models of UV-induced damage, both in vitro (HaCaT cells) and ex vivo (human skin organ culture). Then, a clinical validation study (n = 33) was performed using an optimized topical cream formulation tested at different time points (up to Day 56).
EPA was found to potentiate the protective effects of CBD by reducing the secretion of prostaglandin E2 (PGE ) and interleukin-8 (IL-8), two primary inflammatory agents associated with photoaging. In addition, a qualitative histological examination signaled that applying the cream may result in an increase in extracellular matrix (ECM) remodeling following UV radiation. This was also evidenced clinically by a reduction of crow's feet wrinkle area and volume, as well as a reduction of fine line wrinkle volume as measured by the AEVA system. The well-established age-dependent subepidermal low-echogenic band (SLEB) was also reduced by 8.8%. Additional clinical results showed significantly reduced red spots area and count, and an increase in skin hydration and elasticity by 31.2% and 25.6% following 56 days of cream application, respectively. These impressive clinical results correlated with high satisfaction ratings by the study participants.
Collectively, the results show a profound anti-aging impact of the developed formulation and strengthen the beneficial derm-cosmetic properties of CBD-based products.
皮肤老化表现,如粗大皱纹、弹性丧失、色素沉着和质地粗糙等,是一个多因素过程,空气污染、吸烟、营养不良和阳光照射会加剧这一过程。紫外线辐射被认为是外在皮肤老化的主要原因,约占面部老化的80%。外在皮肤老化迹象可通过美容配方减轻。大麻二酚(CBD)和二十碳五烯酸(EPA)此前均被认为是有效的活性皮肤成分。
本研究的目的是评估这两种成分在预防和治疗皮肤老化方面的兼容性。首先,在体外(HaCaT细胞)和离体(人皮肤器官培养)条件下,使用紫外线诱导损伤的标准光老化模型评估这两种成分的影响。然后,进行了一项临床验证研究(n = 33),使用一种优化的外用乳膏配方,在不同时间点(直至第56天)进行测试。
发现EPA可通过减少前列腺素E2(PGE)和白细胞介素-8(IL-8)的分泌来增强CBD的保护作用,这两种物质是与光老化相关的两种主要炎症介质。此外,定性组织学检查表明,涂抹该乳膏可能会导致紫外线辐射后细胞外基质(ECM)重塑增加。这在临床上也得到了证实,通过鱼尾纹皱纹面积和体积的减少,以及通过AEVA系统测量的细纹皱纹体积的减少。公认的年龄依赖性表皮下低回声带(SLEB)也减少了8.8%。额外的临床结果显示,涂抹乳膏56天后,红斑面积和数量显著减少,皮肤水合作用和弹性分别增加31.2%和25.6%。这些令人印象深刻的临床结果与研究参与者的高满意度评分相关。
总体而言,结果显示了所开发配方具有显著的抗衰老作用,并强化了基于CBD产品的有益皮肤美容特性。